Bowhead Specialty Holdings Inc.
NYSE · us_market
No AI summary generated yet for this ticker.
Bowhead Specialty Holdings Inc. provides commercial specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions, including directors and officers liability, errors and omissions liability, employment practices liability, fiduciary liability, fidelity liability and miscellaneous professional liability, crime insurance, and cyber for financial institutions; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and management liability segments. In addition, it offers Baleen Specialty, a technology-powered underwriting operation, that specializes in small to mid-sized risks that are not eligible in the admitted market. It distributes its products through distribution partners in wholesale and retail markets. The company was formerly known as Bowhead Holdings Inc. and changed its name to Bowhead Specialty Holdings Inc. in March 2024. The company was founded in 2020 and is based in New York, New York.
The United States market has shown robust growth, with a 1.8% increase over the last week and a remarkable 28% rise over the past year, while earnings are projected to grow by 17% annually. In such an environment, identifying stocks that may be trading below their estimated value can offer investors potential opportunities for capitalizing on future growth.
The United States market has shown robust performance, rising 1.8% over the last week and climbing 28% in the past year, with earnings projected to grow by 17% annually. In this thriving environment, identifying stocks that are trading below their estimated value can offer potential opportunities for investors looking to capitalize on market growth while minimizing risk.
Over the last seven days, the United States market has experienced a 1.3% rise, contributing to a 28% increase over the past year, with earnings forecasted to grow by 17% annually. In such an environment, identifying stocks that are potentially trading below their estimated value can be key for investors looking to capitalize on future growth opportunities.
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
Over the last 7 days, the United States market has risen by 1.3%, and over the past year, it has climbed an impressive 28%, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets.
The United States market has shown robust performance with a 2.5% increase over the last week and a remarkable 26% rise in the past year, while earnings are projected to grow by 17% annually. In this thriving environment, identifying stocks that may be trading below their estimated value can offer compelling opportunities for investors seeking to capitalize on potential growth at attractive prices.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Morgan Stanley analyst Bob Huang maintains Bowhead Specialty Hldgs (NYSE:BOW) with a Equal-Weight and raises the price target from $27 to $28.
Bowhead Specialty’s first quarter was marked by significant revenue and earnings outperformance versus Wall Street expectations, driven by robust growth across its specialty insurance divisions and broad adoption of its digital underwriting platforms. Management credited the quarter’s results to disciplined premium growth in casualty lines and continued expansion in digital initiatives such as Baleen and Bowhead Express. CEO Stephen Sills emphasized strong execution in the excess casualty and cy
In the last week, the United States market has stayed flat, yet it is up 25% over the past year with earnings anticipated to grow by 17% annually in the coming years. In this context of overall growth and stability, identifying stocks that may be trading at an estimated discount can offer investors potential opportunities for value investing.
Keefe, Bruyette & Woods analyst Meyer Sheilds maintains Bowhead Specialty Hldgs (NYSE:BOW) with a Outperform and raises the price target from $31 to $34.
Morgan Stanley analyst Bob Huang maintains Bowhead Specialty Hldgs (NYSE:BOW) with a Equal-Weight and raises the price target from $25 to $27.
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Bowhead Specialty Holdings Inc. (BOW) Discusses Technology and AI Advancements in Specialty Insurance Underwriting and Operations May 6, 2026 8:00 AM...
Presentation Operator MessageOperator All right. Cave, go ahead.Presenter SpeechCave Montazeri Thank you. Good morning, everyone, and thank you for joining us today. My name is Cave Montazeri, and...
Bowhead Specialty (NYSE:BOW) reported a strong start to 2026, highlighted by premium growth across all divisions and higher profitability, while management also detailed progress in its digital underwriting strategy spanning Baleen Specialty and Bowhead Express. Premium growth led by Casualty and d
Moby summary of Bowhead Specialty Holdings Inc.'s Q1 2026 earnings call
Bowhead Specialty Holdings Inc. (BOW) Q1 2026 Earnings Call May 5, 2026 8:30 AM EDTCompany ParticipantsShek Yap - Chief Accounting Officer & Head of...
Presentation Operator MessageOperator Hello, and welcome to Bowhead Specialty Q1 2026 Earnings Call. [Operator Instructions] Also, as a reminder, this conference is being recorded. If you have any...
While the top- and bottom-line numbers for Bowhead Specialty Holdings Inc. (BOW) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| TwoSigma | quant | 518.7K | $11.63M | 0.01% | Added+55.3% | 2026-03-31 |
| StateStreet | passive | 397.0K | $8.90M | 0.00% | Added+4.8% | 2026-03-31 |
| RenTech | quant | 53.4K | $1.20M | 0.00% | Trimmed-77.3% | 2026-03-31 |
| Citadel | multi-strat | 13.4K | $301.10K | 0.00% | New | 2026-03-31 |
| FidelityFMR | fundamental | 7.3K | $163.75K | 0.00% | Trimmed-35.2% | 2026-03-31 |
| TRowePrice | fundamental | 189.5K | $4.25K | 0.00% | Added+551.3% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-04upcoming | 0.47 | — | — |
| 2026-05-05 | 0.41 | 0.48 | +15.67% |
| 2026-02-24 | 0.44 | 0.47 | +6.03% |
| 2025-11-04 | 0.41 | 0.47 | +15.19% |
| 2025-08-05 | 0.36 | 0.37 | +3.48% |
| 2025-05-06 | 0.33 | 0.34 | +4.44% |
| 2025-02-25 | 0.33 | 0.42 | +29.21% |
| 2024-11-05 | 0.35 | 0.38 | +9.42% |
| 2024-08-06 | 0.26 | 0.28 | +6.06% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| BOW | +9.46% | +7.12% | -6.73% | -28.63% |
| XLF | -0.65% | +0.72% | -5.82% | +1.22% |
| Alpha (stock − sector) | +10.11% | +6.40% | -0.90% | -29.85% |